Kowa Pharmaceutical Europe Co. Ltd.

Innovation through collaboration

Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK and is a division of Kowa Company, Ltd., a multinational Japanese company actively engaged in a broad variety of manufacturing and trading activities.  Kowa are committed to improving health standards in Europe and globally.

Our treatment areas

We proudly supply a wide range of products from prescription medicines to
retinal cameras and other medical diagnostic products.

  • Dyslipidemia
  • Type 2 Diabetes
  • Arteriosclerotic disease
  • Cancer
  • Inflammatory disease
  • Skin disease
Sensory organ
  • Eye disease
  • Equilibrium and auditory function disorders
  • Non-Mydriatic Retinal Cameras
  • Combination Retinal Cameras
  • Portable Retinal Cameras
  • Software
  • Refraction
  • Diagnostic
  • Anterior

Kowa is committed to the global healthcare community.



Fiscal year March 2023
(Kowa Group Consolidated)



 March 2023 (Kowa Group


Major subsidiaries

Subsidiaries in Japan, Asia, North America, Latin America, and Europe., March 2023

Report adverse event

Kowa routinely monitors the safety of all its medicines. This includes review of safety data from clinical studies, and collection of reports and cases of adverse events for marketed products.

Patients and Volunteers in clinical trials reporting an adverse event must contact the investigator.

For specific medical information requests please visit the relevant product page to get in touch.

For the reporting of Livazo adverse events within Europe Union please contact local distributor or Recordati

For the reporting of Livazo adverse events within Middle East and North Africa (MENA) please contact...

Contact us

    I confirm I have read and accept the terms of the Privacy policy